Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus.
Variations in systemic lupus erythematosus (SLE) clinical manifestations, serologies and outcomes have been related to gender differences. However, these associations have not been evaluated in Puerto Ricans. A cross-sectional study was performed in a cohort of 235 Puerto Rican SLE patients. Clinical variables, autoantibodies, SLICC/ACR damage index and mortality rate were determined. Of the 235 SLE patients, 12 (5%) were males. Male and female patients were similar with respect to age, disease duration and follow up. Men were more likely to have pericardial effusion (41% vs 5%, p<0.01), pleural effusion (58% vs 10%, p<0.01), proteinuria (>0.5 g/24 hr) (58% vs 24%, p=0.02), renal insufficiency (42% vs 11%, p<0.01) and end-stage renal disease (33% vs 6%, p<0.01) than women. Anti-Sm antibodies (60.0% vs 13%, p<0.01) and anti-snRNP antibodies (56% vs 21%, p=0.03) were more prevalent in men. SLICC/ACR mean damage index (2.7 +/- 2.7 vs 1.0 +/- 1.6, p<0.01) and mortality rate (25% vs 4.5%, p=0.02) were higher in men. In conclusion, male SLE patients of this cohort had higher prevalence of serositis and renal involvement than women. They also had a poorer outcome, presenting higher disease damage and mortality.
Mayor
A M
AM
Retrovirus Research Center, Universidad Central del Caribe, School of Medicine, Bayamón, Puerto Rico, USA. amayorb@hotmail.com
Vilá
L M
LM
D000293:Adolescent; D000328:Adult; D001323:Autoantibodies / Q000097:blood; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000453:epidemiology* / Q000276:immunology / Q000401:mortality; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D011647:Puerto Rico / Q000453:epidemiology; D012700:Serositis / Q000209:etiology; D012720:Severity of Illness Index; D012737:Sex Factors; D015996:Survival Rate
D001323:Autoantibodies